Baby Safety / Compounds / Deferoxamine (Desferal / DFO / desferrioxamine B)

Is Deferoxamine (Desferal / DFO / desferrioxamine B) safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to Deferoxamine (Desferal / DFO / desferrioxamine B) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is deferoxamine (desferal / dfo / desferrioxamine b)?

The IUPAC name is N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide.

Also known as: deferoxamine, 70-51-9, Desferrioxamine B, DESFERRIOXAMINE.

IUPAC name
N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide
CAS number
70-51-9
Molecular formula
C25H48N6O8
Molecular weight
560.7 g/mol
SMILES
CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
PubChem CID
2973

Risk for babies

Very high risk

Infants are more vulnerable to Deferoxamine (Desferal / DFO / desferrioxamine B) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Regulatory consensus

3 regulatory and scientific bodies have classified Deferoxamine (Desferal / DFO / desferrioxamine B). The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA—Approved drug (NDA 016267) for iron overload and acute iron poisoning
WHO—Essential Medicine — iron overload and acute poisoning
EMA—Approved; well-established use

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter deferoxamine (desferal / dfo / desferrioxamine b)

  • Pharmaceutical — iron chelation therapy (thalassemia), acute iron poisoning antidote
  • Medical — subcutaneous infusion pump (nightly), IV infusion during transfusion
  • Research — iron metabolism studies, siderophore biology

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Deferoxamine (Desferal / DFO / desferrioxamine B):

  • Deferasirox (Exjade/Jadenu)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 1.2-2×
  • Deferiprone (Ferriprox)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 1.2-2×

Frequently asked questions

Is deferoxamine (desferal / dfo / desferrioxamine b) safe for kids?

Infants are more vulnerable to Deferoxamine (Desferal / DFO / desferrioxamine B) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain deferoxamine (desferal / dfo / desferrioxamine b)?

Deferoxamine (Desferal / DFO / desferrioxamine B) appears in: iron chelation therapy (thalassemia) (pharmaceutical); acute iron poisoning antidote (pharmaceutical); subcutaneous infusion pump (nightly) (medical); IV infusion during transfusion (medical); iron metabolism studies (research).

What should I do if my child is exposed to deferoxamine (desferal / dfo / desferrioxamine b)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about deferoxamine (desferal / dfo / desferrioxamine b)?

Deferoxamine (Desferal / DFO / desferrioxamine B) has been classified by 3 agencies including FDA, WHO, EMA, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Deferoxamine (Desferal / DFO / desferrioxamine B) in the baby app

Look up products containing deferoxamine (desferal / dfo / desferrioxamine b), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. — expert_curation

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →